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Abstract:
Background. Colorectal cancer is the third most commonly diagnosed cancer, as well as the third
leading cause of cancer mortality in the United States. Ulcerative colitis (UC), a chronic
inflammatory disease of the colon, has been shown to increase the incidence of colorectal
cancer. Approximately 20% of UC patients are projected to develop colorectal carcinoma
during their life-time. Chronic colitis increases the likelihood of epithelial dysplasia and
adenocarcinoma of the colon.
Objective. Our objective is to integrate two mechanistic disease models into a single murine
model in which to investigate the effects of inflammation on colorectal cancer development. We
hypothesize that our new interactive murine model will allow us to investigate the potential
interactive effects of chronic colitis on colonic adenocarcinoma tumor characteristics.
Furthermore, we hypothesize that the colitic inflammatory milieu will augment tumor growth,
potentiate neoangiogenesis, alter leukocytic infiltrates and modulate enteric neuroplasticity.
Methods. The colitis component of the colitis/cancer model was constructed using C57Bl/6 that
were fed water or dextran sodium sulfate (DSS) 3% until sacrifice on day 10. Colons were
grossly and histologically inspected (N=5,5). Spatial distribution of neutrophil infiltrates were
quantified using a novel lamina propria (LP)/muscularis externa (ME) whole-mount

preparation (N=6). Colonic tissue and serum cytokines were determined using a MAGPIX
cytokine panel (N=6,6). The cancer component of the colitis/cancer model was constructed by
the colonic submucosal injection of a C57Bl/6 adenocarcinoma cell line (MC38 – 50,000 cells).
Spatial distribution of neutrophilic infiltrates were quantified using the lamina
propria/muscularis externa (ME) whole-mount preparation. On-going experiments will
characterize tumor development, including: tumor growth, neoangiogenesis, molecular
inflammatory responses and recruited leukocytic phenotyping.
Results. At sacrifice, colonic DSS histology exhibited hemorrhagic mucosal sloughing. Analysis
of neutrophilic infiltrates within the lamina propria demonstrated DSS-induced dense cellular
infiltrates that were clustered around the lamina propria venules (cntrl=162.0±6.01 vs.
DSS=48.4±8.05 luminosity, 100X field). DSS colonic ME whole-mounts had a mild significant
increased presence of neutrophils compared to controls (cntrl=1.5±0.97 vs. DSS=24.2±1.3, 100X
field). Immune analysis of the conditioned media of the organ cultured LP/ME tissue
demonstrated significant increases in VEGF, IL-10, MIP-1α & GM-CSF compared to control.
Serum cytokines also showed a systemic inflammatory response (VEGF, IL-6 & MCP-1). In
regards to the colon cancer model, two weeks after MC38 adenocarcinoma injection into the
colonic submucosal space, a discrete neoplastic growth was microscopically visualized within
the lamina propria. Interestingly, an intense myeloperoxidase-positive neutrophilic and
monocytic inflammatory response enveloped the focal neoplasm. Additionally, a diffuse
transmural myeloperoxidase-positive neutrophilic inflammatory response was observed
extending beyond the neoplasm.

Conclusion. We have successfully developed individual models of colitis and colon cancer,
which can be easily combined to produce a unique and novel interactive colitis/cancer model.
We propose that the novel murine colitis/cancer model will allow us to gather crucial data
regarding the interactive colitic tumor microenvironment. Pending the results of the study,
targeting specific inflammatory mediators could be used as a potential therapeutic intervention
for cancer prevention and treatment.

